App-Quantinova.ai

Incidence of thromboembolism (TE) in patients with melanoma receiving immune checkpoint inhibitor (ICI) therapy and its adverse impact on survival

Tamara Sussman - International Society for Biological Therapy of Cancer (SITC) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

LEFT ATRIAL CLOSURE DEVICE THROMBOSIS IS ASSOCIATED WITH SYSTEMIC EMBOLIZATION

Pavel Hala - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

ASSOCIATION BETWEEN PERSONALIZED EVIDENCE-BASED ANTICOAGULATION THERAPY AND OUTCOMES AT 1-YEAR FOLLOW-UP IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS FROM THE ATRIAL FIBRILLATION REGISTRY

Evgeny A. Pokushalov - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

INCIDENCE OF DEVICE-RELATED THROMBOSIS IN WATCHMAN PATIENTS UNDERGOING A GENOTYPE-GUIDED ANTITHROMBOTIC STRATEGY

Domenico G. Della Rocca - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Clopidogrel bisulfate

CARDIAC IMPLANTABLE ELECTRONIC DEVICE OUTCOMES AT A LARGE CANADIAN CARDIAC CENTER

Roupen Odabashian - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

DOUBLE PROGLIDE PRECLOSE TECHNIQUE FOR VASCULAR ACCESS CLOSURE AFTER LEADLESS PACEMAKER IMPLANTATION

Amrish Deshmukh - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

LEFT ATRIAL APPENDAGE OCCLUSION WITH NEW WATCHMAN-FLX DEVICE

Jalaj Garg - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

MULTI-PHYSICS, PATIENT-SPECIFIC COMPUTATIONAL MODELING OF LA ELECTROPHYSIOLOGY, BIOMECHANICS AND HEMODYNAMICS REVEALS MECHANISTIC CONNECTIONS BETWEEN FIBROTIC REMODELING AND THROMBOSIS RISK

Alejandro Gonzalo - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

A NEW CLINICAL DECISION SUPPORT TOOL BASED ON PERSONALIZED EVIDENCE-BASED MEDICINE IMPROVES OUTCOMES OF ANTICOAGULATION THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS FROM THE ATRIAL FIBRILLATION REGISTRY

Evgeny A. Pokushalov - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

DIFFERENCES IN STROKE OR SYSTEMIC THROMBOEMBOLISM READMISSIONS AFTER HOSPITALIZATION FOR ATRIAL FIBRILLATION OR ATRIAL FLUTTER

Harshith Thyagaturu - Heart Rhythm Society (HRS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant

T. Sam - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

apixaban

Corticosteroid Reintroduction in Urban Simultaneous Kidney-pancreas Transplant Recipients Following an Early Corticosteroid Withdrawal Protocol

D. Pierce - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Mycophenolic acid

Early Increases in Post-Transplant Pancreatic Enzymes Are Associated with Surgical Complications Among Pancreas Transplant Recipients

S. Parajuli - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

lipase

Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation

H. Fernandez - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Is Low Systemic Fibrinolytic Activity During the Anhepatic Phase Liver Transplant Surgery Associate with the Dreaded Post-Operative Complication of Hepatic Artery Thrombosis?

H. B. Moore - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy

R. Hogen - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictive Factors of the Hepatic Artery Thrombosis in Liver Transplantation Through the Analysis of Donor Characteristics

M. M. Pascale - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Epinephrine

Re-Do Hepatic Artery Reconstruction for Thrombosis Can Save Grafts and Patients without Retransplantation: Lessons Learned from 1,355Adult Living Donor Liver Transplantations

S. Hong - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss

R. Valero - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Mycophenolic acid

The Combined Effects of Simultaneous Portal Vein Thrombosis and Renal Dysfunction in Liver Transplant Recipients

M. Molinari - American Transplant Congress (ATC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts